Plus Therapeutics Stock Price History
PSTV Stock | USD 0.56 0.03 5.08% |
If you're considering investing in Plus Stock, it is important to understand the factors that can impact its price. As of today, the current price of Plus Therapeutics stands at 0.56, as last reported on the 19th of March, with the highest price reaching 0.61 and the lowest price hitting 0.53 during the day. Plus Therapeutics is out of control given 3 months investment horizon. Plus Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of 0.0631, which implies the firm had a 0.0631 % return per unit of risk over the last 3 months. We were able to interpolate and analyze data for thirty different technical indicators, which can help you to evaluate if expected returns of 2.65% are justified by taking the suggested risk. Use Plus Therapeutics Semi Deviation of 11.8, risk adjusted performance of 0.0654, and Coefficient Of Variation of 1583.59 to evaluate company specific risk that cannot be diversified away.
Plus Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Plus |
Sharpe Ratio = 0.0631
Best Portfolio | Best Equity | |||
Good Returns | PSTV | |||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
42.0 actual daily | 96 96% of assets are less volatile |
Expected Return
2.65 actual daily | 52 52% of assets have lower returns |
Risk-Adjusted Return
0.06 actual daily | 4 96% of assets perform better |
Based on monthly moving average Plus Therapeutics is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Plus Therapeutics by adding it to a well-diversified portfolio.
Plus Therapeutics Stock Price History Chart
There are several ways to analyze Plus Stock price data. The simplest method is using a basic Plus candlestick price chart, which shows Plus Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | March 7, 2025 | 1.57 |
Lowest Price | March 4, 2025 | 0.3 |
Plus Therapeutics March 19, 2025 Stock Price Synopsis
Various analyses of Plus Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Plus Stock. It can be used to describe the percentage change in the price of Plus Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Plus Stock.Plus Therapeutics Price Action Indicator | (0.02) | |
Plus Therapeutics Price Daily Balance Of Power | (0.37) | |
Plus Therapeutics Price Rate Of Daily Change | 0.95 |
Plus Therapeutics March 19, 2025 Stock Price Analysis
Plus Stock Price History Data
The price series of Plus Therapeutics for the period between Thu, Dec 19, 2024 and Wed, Mar 19, 2025 has a statistical range of 1.27 with a coefficient of variation of 23.7. The price distribution for the period has arithmetic mean of 1.09. The median price for the last 90 days is 1.2. The company completed stock split (1:15) on 1st of May 2023. Plus Therapeutics had dividends distributed to its stock-holders on 2019-08-06.Open | High | Low | Close | Volume | ||
03/19/2025 | 0.56 | 0.61 | 0.53 | 0.56 | ||
03/18/2025 | 0.56 | 0.61 | 0.53 | 0.56 | 3,352,907 | |
03/17/2025 | 0.70 | 0.70 | 0.56 | 0.59 | 2,231,046 | |
03/14/2025 | 0.70 | 0.72 | 0.60 | 0.68 | 2,428,411 | |
03/13/2025 | 1.10 | 1.10 | 0.75 | 0.75 | 3,511,085 | |
03/12/2025 | 1.41 | 1.47 | 1.16 | 1.21 | 2,917,453 | |
03/11/2025 | 1.28 | 1.89 | 1.28 | 1.43 | 23,403,919 | |
03/10/2025 | 1.42 | 1.66 | 1.25 | 1.27 | 5,270,535 | |
03/07/2025 | 2.02 | 2.31 | 1.27 | 1.57 | 102,615,083 | |
03/06/2025 | 0.57 | 1.54 | 0.47 | 1.44 | 359,585,000 | |
03/05/2025 | 0.33 | 0.37 | 0.31 | 0.35 | 1,069,477 | |
03/04/2025 | 0.65 | 0.69 | 0.24 | 0.30 | 4,779,600 | |
03/03/2025 | 0.70 | 0.72 | 0.63 | 0.66 | 282,042 | |
02/28/2025 | 0.71 | 0.85 | 0.68 | 0.73 | 1,129,284 | |
02/27/2025 | 0.75 | 0.75 | 0.65 | 0.68 | 317,900 | |
02/26/2025 | 1.00 | 1.00 | 0.74 | 0.76 | 381,999 | |
02/25/2025 | 1.19 | 1.19 | 1.08 | 1.08 | 47,052 | |
02/24/2025 | 1.15 | 1.19 | 1.10 | 1.14 | 72,524 | |
02/21/2025 | 1.20 | 1.20 | 1.09 | 1.20 | 68,918 | |
02/20/2025 | 1.17 | 1.30 | 1.17 | 1.20 | 163,199 | |
02/19/2025 | 1.17 | 1.20 | 1.17 | 1.20 | 9,629 | |
02/18/2025 | 1.19 | 1.20 | 1.17 | 1.18 | 42,131 | |
02/14/2025 | 1.21 | 1.25 | 1.16 | 1.24 | 39,299 | |
02/13/2025 | 1.12 | 1.26 | 1.12 | 1.20 | 53,441 | |
02/12/2025 | 1.26 | 1.26 | 1.12 | 1.12 | 26,147 | |
02/11/2025 | 1.28 | 1.33 | 1.20 | 1.23 | 29,000 | |
02/10/2025 | 1.22 | 1.24 | 1.22 | 1.22 | 5,433 | |
02/07/2025 | 1.25 | 1.28 | 1.22 | 1.24 | 16,059 | |
02/06/2025 | 1.29 | 1.32 | 1.22 | 1.28 | 18,598 | |
02/05/2025 | 1.25 | 1.30 | 1.24 | 1.28 | 30,046 | |
02/04/2025 | 1.23 | 1.30 | 1.21 | 1.25 | 40,900 | |
02/03/2025 | 1.21 | 1.25 | 1.18 | 1.24 | 29,800 | |
01/31/2025 | 1.22 | 1.26 | 1.20 | 1.24 | 28,600 | |
01/30/2025 | 1.21 | 1.26 | 1.18 | 1.20 | 8,300 | |
01/29/2025 | 1.20 | 1.22 | 1.18 | 1.20 | 5,700 | |
01/28/2025 | 1.21 | 1.25 | 1.18 | 1.19 | 13,300 | |
01/27/2025 | 1.21 | 1.26 | 1.21 | 1.23 | 20,400 | |
01/24/2025 | 1.21 | 1.23 | 1.21 | 1.23 | 15,500 | |
01/23/2025 | 1.20 | 1.22 | 1.19 | 1.21 | 6,412 | |
01/22/2025 | 1.23 | 1.25 | 1.22 | 1.22 | 7,406 | |
01/21/2025 | 1.21 | 1.24 | 1.21 | 1.24 | 10,538 | |
01/17/2025 | 1.21 | 1.21 | 1.16 | 1.17 | 8,784 | |
01/16/2025 | 1.20 | 1.22 | 1.19 | 1.19 | 12,562 | |
01/15/2025 | 1.18 | 1.24 | 1.18 | 1.20 | 18,770 | |
01/14/2025 | 1.15 | 1.20 | 1.15 | 1.17 | 16,129 | |
01/13/2025 | 1.14 | 1.24 | 1.12 | 1.14 | 18,587 | |
01/10/2025 | 1.20 | 1.22 | 1.14 | 1.16 | 16,356 | |
01/08/2025 | 1.32 | 1.35 | 1.15 | 1.20 | 75,586 | |
01/07/2025 | 1.30 | 1.30 | 1.23 | 1.24 | 36,089 | |
01/06/2025 | 1.25 | 1.30 | 1.21 | 1.26 | 72,207 | |
01/03/2025 | 1.20 | 1.24 | 1.18 | 1.23 | 44,068 | |
01/02/2025 | 1.14 | 1.19 | 1.14 | 1.18 | 29,436 | |
12/31/2024 | 1.19 | 1.23 | 1.10 | 1.15 | 40,123 | |
12/30/2024 | 1.18 | 1.18 | 1.09 | 1.15 | 43,799 | |
12/27/2024 | 1.11 | 1.17 | 1.09 | 1.16 | 38,534 | |
12/26/2024 | 1.07 | 1.10 | 1.04 | 1.08 | 28,927 | |
12/24/2024 | 1.07 | 1.11 | 1.07 | 1.08 | 7,049 | |
12/23/2024 | 1.14 | 1.14 | 1.03 | 1.07 | 40,975 | |
12/20/2024 | 1.01 | 1.11 | 0.97 | 1.09 | 49,387 | |
12/19/2024 | 1.01 | 1.10 | 0.93 | 0.99 | 84,117 | |
12/18/2024 | 1.07 | 1.10 | 0.98 | 1.00 | 79,404 |
About Plus Therapeutics Stock history
Plus Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Plus is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Plus Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Plus Therapeutics stock prices may prove useful in developing a viable investing in Plus Therapeutics
Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer and other diseases. Plus Therapeutics, Inc. was founded in 1996 and is headquartered in Austin, Texas. Plus Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 14 people.
Plus Therapeutics Stock Technical Analysis
Plus Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Content Syndication Now
Content SyndicationQuickly integrate customizable finance content to your own investment portal |
All Next | Launch Module |
Plus Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Plus Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Plus Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Plus to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0654 | |||
Jensen Alpha | 3.45 | |||
Total Risk Alpha | 7.27 | |||
Sortino Ratio | 0.1748 | |||
Treynor Ratio | 0.3162 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for Plus Stock Analysis
When running Plus Therapeutics' price analysis, check to measure Plus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Plus Therapeutics is operating at the current time. Most of Plus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Plus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Plus Therapeutics' price. Additionally, you may evaluate how the addition of Plus Therapeutics to your portfolios can decrease your overall portfolio volatility.